NEW YORK, NY – November 30, 2020 – RADLogics™ today announced the availability of the latest version of the company's AI-Powered COVID-19 CT algorithm. Building on the company's AI-Powered solution that has processed and analyzed hundreds of thousands of suspected Coronavirus cases globally, the latest update delivers a complex deep learning system consisting of several models utilized to detect, localize and segment regions in the lungs infected with COVID-19. With Coronavirus cases again surging across the U.S. along with hospitalizations, AI-Powered solutions are poised to not only alleviate the increased burden associated with COVID-19, but to help support improved outcomes by reducing burnout and errors.
As part of RADLogics' latest version of its algorithm, three different analyses can now be performed simultaneously on raw chest CT image scans including: 1) a lungs region-of-interest are cropped with lung abnormalities detected; 2) the lung lobes are segmented and; 3) if the nodules plug-in is activated, focal Ground Glass Opacities (GGOs) are detected. According to leading physicians, these measurements are key features in determining patient classification into COVID-19 and non-COVID-19 indications. The overall system produces the decision whether the case is suspected for COVID-19 with a confidence level (in percentages). These measurements along with other features are used by radiologists to distinguish between COVID-19 and other abnormalities such as common pneumonia.
A close up of a sign
Ad Statistics
Times Displayed: 172547
Times Visited: 3115 For those who need to move fast and expand clinical capabilities -- and would love new equipment -- the uCT 550 Advance offers a new fully configured 80-slice CT in up to 2 weeks with routine maintenance and parts and Software Upgrades for Life™ included.
Description automatically generated
RADLogics AI-Powered COVID-19 solutions provide quantitative analysis to clinical teams that perform testing and measurement of patients with severe or worsening respiratory
"With the U.S. in the midst of an unprecedented rise in COVID-19 infections, with current hospitalizations at an all-time record of more than 90,000 patients, there is an increasing need for AI solutions in medical imaging," said Moshe Becker, CEO and Co-Founder of RADLogics. "Coronavirus-related infection rates are experiencing a sharp increase in most states – from rural communities to urban areas – that have the potential to overwhelm ER, ICU and radiology teams with a surge of patients, and AI-Powered medical imaging analysis solutions are poised to reduce this pressure through improved patient triage, monitoring and management."
Since the pandemic started earlier this year, RADLogics has responded with the deployment of the company's AI-Powered medical image analysis solution worldwide. In accordance with FDA guidance for imaging systems and software to address the COVID-19 public health emergency, RADLogics has made its FDA cleared CT and X-ray solutions available to hospitals and healthcare systems throughout the U.S. for patient triage and management. Designed for easy installation and integration both on-site and via the cloud, RADLogics' algorithms are supported by the company's patented software platform that enables rapid deployment at multiple hospitals, and seamless integration with existing workflows. All of the company's AI-Powered solutions are available worldwide through major OEM distribution partners including Nuance via the AI Marketplace in the U.S. market.
